LGND
LIGAND PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$317.33
−0.45%0
Insider buys (3m)
24
Insider sells (3m)
-$16.1M
Net value (3m)
+6.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 6, 2026 | Reardon Andrew · officer: CLO & Secretary | M-Exempt | 340 | $52 |
| Oct 6, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 17 | $308 |
| Oct 6, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 1,535 | $305 |
| Oct 6, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 833 | $303 |
| Oct 6, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 404 | $306 |
| Oct 6, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 235 | $307 |
| Oct 6, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 1,976 | $304 |
| Sep 24, 2026 | Zimmermann Martine · director | F-InKind | 115 | $299 |
| Sep 14, 2026 | Zimmermann Martine · director | Sale | 1,200 | $285 |
| Sep 8, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 1,800 | $285 |
| Sep 8, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 385 | $288 |
| Sep 8, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 300 | $284 |
| Sep 8, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 2,115 | $286 |
| Sep 8, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 400 | $289 |
| Aug 14, 2026 | Haas Jason · director | M-Exempt | 6,138 | $52 |
| Aug 14, 2026 | Espinoza Octavio · officer: Chief Financial Officer | M-Exempt | 2,074 | $70 |
| Aug 14, 2026 | Espinoza Octavio · officer: Chief Financial Officer | M-Exempt | 3,348 | $69 |
| Aug 14, 2026 | Espinoza Octavio · officer: Chief Financial Officer | M-Exempt | 7,171 | $57 |
| Aug 14, 2026 | Espinoza Octavio · officer: Chief Financial Officer | Sale | 31,641 | $292 |
| Aug 14, 2026 | Espinoza Octavio · officer: Chief Financial Officer | M-Exempt | 16,179 | $53 |
| Aug 14, 2026 | Espinoza Octavio · officer: Chief Financial Officer | M-Exempt | 2,869 | $56 |
| Aug 14, 2026 | Haas Jason · director | Sale | 7,138 | $293 |
| Aug 4, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 105 | $284 |
| Aug 4, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 1,032 | $287 |
| Aug 4, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 991 | $292 |
| Aug 4, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 200 | $291 |
| Aug 4, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 356 | $289 |
| Aug 4, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 503 | $290 |
| Aug 4, 2026 | Reardon Andrew · officer: CLO & Secretary | Sale | 409 | $293 |
| Aug 4, 2026 | Reardon Andrew · officer: CLO & Secretary | M-Exempt | 5,000 | $52 |
Institutional positioning
13F filings over the trailing two quarters
New 160Increased 292Reduced 244Sold out 36
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 3,100,996 | Aug 7, 2026 |
| BLACKROCK, INC. | Increased | 2,961,923 | May 13, 2026 |
| Invesco Ltd. | Increased | 1,201,644 | Aug 14, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 1,138,316 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 1,100,267 | May 8, 2026 |
| Jupiter Topco LLC | New Position | 1,040,578 | Aug 14, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 1,009,891 | May 18, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 870,950 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 848,089 | May 15, 2026 |
| STATE STREET CORP | Increased | 826,539 | Sep 22, 2026 |
| INVESCO LTD. | Increased | 823,604 | May 12, 2026 |
| STATE STREET CORP | Increased | 778,856 | May 15, 2026 |
| FMR LLC | Increased | 762,827 | Aug 13, 2026 |
| FRANKLIN RESOURCES INC | Increased | 752,044 | Aug 13, 2026 |
| CONGRESS ASSET MANAGEMENT CO | Increased | 659,911 | Jul 7, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 6, 2026